Projects per year
Personal profile
Education
- 2012 Ph.D., Pharmacology Institute, National Taiwan University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2023- Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2023- Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2023- Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2023- Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2023- Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2023- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2021-2023 Associate Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2021-2023 Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2020-2023 Associate Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2019-2023 Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2018-2023 Associate Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2015-2023 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2018 Assistant Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2013-2014 postdoc., Taipei Medical University
- 2012-2013 postdoc., National Taiwan University
Awards
- 2013 Outstanding Research Award for Scholar-in-Training, National Taiwan University
Research Interests
- Cancer Biology, Mechanism study of anticancer drugs
Related Link
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
海綿中萜類化合物對膀胱癌之治療潛力及其分子作用機轉探討(3/3)
Chen, M.-C. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
華蟾素對於多形性膠質母細胞瘤細胞上 皮間質轉化之影響及抗癌機轉探討
Chen, M.-C. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
海綿中萜類化合物對膀胱癌之治療潛力及其分子作用機轉探討(2/3)
Chen, M.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
蓮子心生物鹼化合物於兒童高惡性度神經膠質細胞瘤之抗癌機轉探討
Chen, M.-C. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanisms of Terpenoids from Marine Sponge in Bladder Cancer (1/3)
Chen, M.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)
Chen, M. C., Chen, C. H., Wang, J. C., Tsai, A. C., Liou, J. P., Pan, S. L. & Teng, C. M., Jul 2024, In: Cell Death and Disease. 15, 7, 490.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids
Tang, D. W., Chen, I. C., Chou, P. Y., Lai, M. J., Liu, Z. Y., Tsai, K. K., Cheng, L. H., Zhao, J. X., Cho, E. C., Chang, H. H., Lin, T. E., Hsu, K. C., Chen, M. C. & Liou, J. P., Nov 15 2024, In: European Journal of Medicinal Chemistry. 278, 116801.Research output: Contribution to journal › Article › peer-review
-
Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids
Chou, P. Y., Lai, M. J., Tsai, K. K., Cheng, L. H., Wu, Y. W., Chen, M. C., Pan, S. L., Ho, H. O., Nepali, K. & Liou, J. P., 2024, (Accepted/In press) In: Journal of Medicinal Chemistry. 67, 19, p. 17207-17225 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells
Hsu, H. L., Lin, B. J., Lin, Y. C., Tu, C. C., Nguyen, N. L., Wang, C. C., Chen, M. C. & Chen, C. H., Oct 2023, In: Current Issues in Molecular Biology. 45, 10, p. 8138-8151 14 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Erratum: N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling (J. Med. Chem. (2015) 58:16 (6549−6558) DOI: 10.1021/acs.jmedchem.5b00659)
Lai, M. J., Lee, H. Y., Chuang, H. Y., Chang, L. H., Tsai, A. C., Chen, M. C., Huang, H. L., Wu, Y. W., Teng, C. M., Pan, S. L., Liu, Y. M., Mehndiratta, S. & Liou, J. P., May 11 2023, In: Journal of Medicinal Chemistry. 66, 9, p. 6436 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms
Lai, M.-J. (Creator), Lee, C.-H. (Creator), Chao, Y.-H. (Creator), Mehndiratta, S. (Creator), Chen, M.-C. (Creator), Liou, J.-P. (Creator) & Lee, H.-Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13207104.v1, https://tandf.figshare.com/articles/journal_contribution/Effect_of_3-subsitution_of_quinolinehydroxamic_acids_on_selectivity_of_histone_deacetylase_isoforms/13207104/1
Dataset